Data presented at the American Heart Association Scientific Sessions show a 67% reduction in bleeding for patients on antiplatelet therapy…
Results show the potential of a real-time, non-invasive blood test to quantify tumor drug target expression and to stratify therapeutic…
50% of patients who had baseline HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the…
Eight participants achieved HBsAg loss at any time.Two participants met criteria for functional cure. Two participants who discontinued NUC therapy…
Significantly greater mean declines in HBsAg levels (p <0.017) were seen in those receiving imdusiran, VTP-300 and low-dose nivolumab compared…
Significantly greater mean declines in HBsAg levels (p <0.017) were seen in those receiving imdusiran, VTP-300 and low-dose nivolumab compared…
The amivantamab plus lazertinib combination regimen offers potential to provide new standard of care as first-line option for adult patients…
The U.S. healthcare revenue cycle management (RCM) outsourcing market for outpatient and ancillary services is experiencing significant growth. In 2023,…
With Growing Demand in Zero Proof and Bubbly Drinks, New Dealcoholized Sparkling Brut and Sparkling Rosé Hit the Spot BOSTON,…
Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions…